N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide

N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide Struktur
1052147-86-0
CAS-Nr.
1052147-86-0
Englisch Name:
N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide
Synonyma:
LP21;LP-211;LP-211 >=98% (HPLC);LP-211; LP 211; LP211;1052147-86-0;N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide;1-Piperazinehexanamide, 4-[1,1'-biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-;LP 211,Inhibitor,5-HT Receptor,Serotonin Receptor,LP-211,5-hydroxytryptamine Receptor,LP211,inhibit
CBNumber:
CB23385434
Summenformel:
C30H34N4O
Molgewicht:
466.62
MOL-Datei:
1052147-86-0.mol

N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide Eigenschaften

Siedepunkt:
714.8±60.0 °C(Predicted)
Dichte
1.17±0.1 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
DMSO:100.0(Max Conc. mg/mL);214.3(Max Conc. mM)
Ethanol:50.0(Max Conc. mg/mL);107.15(Max Conc. mM)
pka
15.39±0.46(Predicted)
Aggregatzustand
solid
Farbe
clear white to light brown

Sicherheit

N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor used in pharmacological studies which showed that it underwent metabolic breakdown to RA-7 and showed pharmacological activities such as induced hypothermia in mice and showed optimal pharmacokinetics in rats.LP-211 is also a drug analogue of piperazinehexanamide exhibiting 5-HT7 receptor affinity.

Biochem/physiol Actions

LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor with a Ki value of 0.58 nM at rat cloned 5-HT7 receptors, and >300-fold selectivity over the 5-HT1A receptor. The 5-HT7 receptor is involved in a variety of central nervous system functions including circadian rhythm, sleep, thermoregulation, nociception, and memory, and appears to be involved in cognitive disorders, anxiety, and depression. LP-211 has been used as a selective 5-HT7 receptor agonist in multiple models including studies as a potential therapeutic agent in models of Rett syndrome and Fragile X Syndrome.

N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 38)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32686 60
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
LEAP CHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 24738 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4153 55
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
3008007409@qq.com China 27322 60
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
2853530910@QQ.com China 8011 62

  • LP-211
  • N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide
  • LP-211; LP 211; LP211;1052147-86-0
  • LP21
  • LP-211 >=98% (HPLC)
  • LP 211,Inhibitor,5-HT Receptor,Serotonin Receptor,LP-211,5-hydroxytryptamine Receptor,LP211,inhibit
  • 1-Piperazinehexanamide, 4-[1,1'-biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-
  • 1052147-86-0
  • API
Copyright 2019 © ChemicalBook. All rights reserved